One researcher described the findings, presented at the Heart Failure Society of America's Annual Scientific Meeting, as "great news for patients and clinicians."
"These findings might imply that not all AFib is worth screening for, and not all screen-detected AFib merits anticoagulation," researchers wrote.
Researchers believe this may be the largest study of its kind.
The Amulet's implantation success rate and LAA closure rate were both higher than the first-generation Watchman device, researchers reported.
Recurrent AFib episodes were much less likely when patients participated in a six-month exercise program.
When drones and ambulances were both sent to the scene of a suspected cardiac arrest, the drone arrived first 64% of the time.
Researchers tracked data from the UK Biobank study, presenting their findings at ESC Congress 2021.
The new analysis, presented at Heart Rhythm 2021, focused on patients from an outpatient arrhythmia clinic.
Researchers presented the new data at Heart Rhythm 2021.
New two-year findings, presented at TVT 2021, suggest that the Watchman FLX device is a safe alternative to long-term oral anticoagulation therapy.
Lead author John Forrest, MD, a cardiologist at Yale School of Medicine, presented the findings at TVT 2021. He noted that it felt great to finally return to in-person conferences after COVID kept people at home for so long.
Patients presenting with an acute myocardial infarction during the start of the COVID-19 pandemic faced delays in care and a higher risk of developing heart failure.
SNMMI is among the many organizations that collaborated on the updated guidance for imaging prostate cancer.
Cordis Corporation warned its device can dislodge during procedures and cause serious adverse events such as heart attack or stroke.
Researchers have used machine learning to track diabetes at the population level.